Amgen intends to sell fixed- and floating-rate notes in five parts

By Devika Patel

Knoxville, Tenn., May 8 – Amgen Inc. is preparing to sell a five-part offering of senior notes with fixed- and floating-rate tranches, according to a 424B3 filing with the Securities and Exchange Commission.

The floating-rate notes are due in 2019 and 2020.

The fixed-rate notes are due 2019, 2020 and 2022.

The floaters are non-callable. The 2019 and 2020 fixed-rate notes will have make-whole calls, and the 2022 fixed-rate notes feature a make-whole call until a month prior to maturity and then a par call.

BofA Merrill Lynch, Goldman Sachs & Co., Barclays and Mizuho Securities USA Inc. are the joint bookrunners.

Proceeds will be used for general corporate purposes.

Amgen is a Thousand Oaks, Calif., manufacturer and marketer of human therapeutics based upon advances in cellular and molecular biology.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.